Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTanta University
About this trial
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients.
Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection.
Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.
Eligibility criteria
Qualifiers
Male or female patients older than 18 years.
Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.
Disqualifiers
Patients aged < 18 years
Unwilling to participate in our study
Trial design
Treatments tested in this trial
- History of IBD course and outcome in HBV patients
Treatment groups
162 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov